Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02786615 · ClinicalTrials.gov registry record · NA
Increasing MSM in the Continuum of Care in Kazakhstan
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 987
- Enrollment target
NCT02786615: Completed NA study, sponsored by Columbia University.
NCT02786615 is a NA study that has completed, run by Columbia University. The registered enrollment target is 987 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02786615, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 987 participants
- Enrollment target
Study Summary
This study addresses the disproportionate representation of men who have sex with men (MSM) in the human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) pandemic in Kazakhstan, a country that has seen some of the largest growth in new HIV infections since the turn of the century. Using a stepped wedge trial across 3 cities in Kazakhstan, the proposed study will test a strategic and innovative social network-based intervention for MSM who use drugs in Kazakhstan as a strategy to increase their numbers in the HIV continuum of care.
Primary Outcome
Has participant received an HIV test in the past 6 months
Interventions
- BEHAVIORAL Peer Unity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 987 participants |
| Start Date | 2018-06-27 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
What the finished NCT02786615 record still lists
NCT02786615 is an interventional study that assigns participants to a tested intervention. The registered 987 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower).
The record links to 0 conditions, and to 1 intervention - of which Peer Unity is the first listed.
NCT02786615 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02786615 about?
NCT02786615 is a clinical study titled "Increasing MSM in the Continuum of Care in Kazakhstan". This study addresses the disproportionate representation of men who have sex with men (MSM) in the human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) pandemic in Kazakhstan, a country that has seen some of the largest growth in new HIV infections since the turn of the centur...
What is the current status of trial NCT02786615?
This trial is currently completed. It is a NA study. The enrollment target is 987 participants. The study started on 2018-06-27. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT02786615?
The interventions under investigation include: Peer Unity (BEHAVIORAL).
Who is sponsoring clinical trial NCT02786615?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02786615's enrollment target sits among peer trials
987 122nd of 2000 higher than 1,879 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079841 · 988 participants · Phase 4
The Stimulation To Induce Mothers Study
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
- NCT06340646 · 990 participants · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- NCT06878261 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI